REFERENCES
- Riesenman, F. R.: Preliminary Report on Thorazine Therapy on Women's Receiving Service, Saint Elizabeth's Hospital, Washington, D.C. Not published.
- Hoffman, J. L. and Konchegul, L.: Clinical and psychological observations on psychiatric patients treated with reserpine. Ann. New York Acad. Sc. 61:144–149 (April 15) 1955. To be published.
ADDITIONAL BIBLIOGRAPHY
- Chlorpromazine
- Barsa, J. A. and Kline, N. S.: Combined reserpine-chlorpromazine therapy in disturbed psychotics: A preliminary report. Am. J. Psychiat. 111:780 (April) 1955.
- Charatan, F. B. E.: Evaluation of chlorpromazine (“largactil”) in psychiatry. J. Ment. Sc. 100:882 (October) 1954.
- Editorial: Chlorpromazine. Lancet 2:637 (September 25) 1954.
- Elkes, J. and Elkes, C.: Effect of chlorpromazine on the behavior of chronically overactive psychotic patients. Brit. M. J. 2:560 (September 4) 1954.
- Goldman, D.: Treatmnt of psychotic states with chlorpromazine. J.A.M.A. 157:1274 (April 9) 1955.
- Lehmann, H. E.: Therapeutic results with chlorpromazine (largactil) in psychiatric conditions. Canad. M. A. J. 72:91 (January 15) 1955.
- Lehmann, H. E. and Hanrahan, G. E.: Chlorpromazine. Arch. Neurol. & Psychiat. 71:227 (February) 1954.
- Winkelman, N. W.: Chlorpromazine in the treatment of neuropsychiatric disorders. J.A.M.A. 155:18 (May 1) 1954.
- Reserpine
- Barsa, J. A. and Kline, N. S.: Combined reserpine-chlorpromazine therapy in disturbed psychotics: A preliminary report. Am. J. Psychiat. 111:780 (April) 1955.
- Dustan, H. P., Taylor, R. D., Corcoran, A. C. and Pace, I. H.: Clinical experience with reserpine (Serpasil): A controlled study. Ann. New York Acad. Sc. 59:136 (April 30) 1954.
- Freis, E. D. and Ari, R.: Clinical and experimental effects of reserpine in patients with essential hypertension. Ann. New York Acad. Sc. 59:45 (April 30) 1954.
- Gaunt, R. and Others: Endocrine Aspects of the Pharmacology of reserpine. Ann. New York Acad. Sc. 59:22 (APRIL 30) 1954.
- Greenblatt, R. B. Use of reserpine (Serpasil) in Certain Gynecologic Disorders. Ann. New York Acad. Sc. 59:133 (April 30) 1954.
- Hafkenschiel, J. H. and Sellers, A. M.: Intravenous reserpine in patients with essential hypertension. Ann. New York Acad. Sc. 59:54 (April 30) 1954.
- Harris, R.: Clinical use of reserpine (Serpasil) in geriatrics. Ann. New York Acad. Sc. 59:95 (April 30) 1954.
- Kline, N. S.: Use of Rauwolfia serpentina Benth. in neuropsychiatry conditions. Ann. New York Acad. Sc. 59:107 (April 30) 1954.
- Moyer, J. H.: Cardiovascular and renal hemodynamic response to reserpine (Serpasil), and clinical results of using this agent for the treatment of hypertension. Ann. New York Acad. Sc. 59:82 (April 30) 1954.
- Noce. R. H., Williams, D. B. and Rapaport, W.: Reserpine (Serpasil) in the management of the mentally ill and the mentally retarded. J.A.M.A. 156:821 (October 30) 1954.
- Plummer, A. J. and Others: Pharmacology of Rauwolfia alkaloids, including reserpine. Ann. New York Acad. Sc. 59:8 (APRIL 30) 1954.
- Schlitter, E. and Others: Chemistry of Rauwolfia alkaloids, including reserpine. Ann. New York Acad. Sc. 59:1 (APRIL 30) 1954.
- Schneider, J. A. and Earl, A. F.: Effects of Serpasil on behavior and autonomic regulating mechanisms. Neurology 4:657 (September) 1954.
- Wilkins, R. W.: Clinical usage of Rauwolfia alkaloids, including reserpine (Serpasil). Ann. New York Acad. Sc. 59:36 (April 30) 1954.
- Winsor, T.: Human pharmacology of reserpine. Ann. New York Acad. Sc. 59:61 (April 30) 1954.